GlassScriptPhysician profile
Brooke Saunders
NPI 1225602493
$1,423.45
in general payments reported to CMS, 2019-2025
19 companies · $211 in 2025
The $211 reported for 2025 was more than what 76% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $76.34 · 2022: $432 · 2023: $358 · 2024: $346 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $915.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $914.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $352.40 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $186.58 | 2022-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $166.53 | 2021-2024 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Tris Pharma INC | $156.93 | 2021-2022 | |
| Seqirus USA INC | $125.15 | 2021-2025 | Flucelvax Quadrivalent, Flucelvax |
| Supernus Pharmaceuticals, INC. | $113.28 | 2023-2024 | Qelbree, Qelbree |
| Collegium Pharmaceutical, INC. | $95.11 | 2025 | Jornay Pm |
| Kaleo, INC. | $34.11 | 2021-2022 | |
| Ars Pharmaceuticals Operations, INC. | $24.86 | 2025 | Neffy |
| Sobi, INC | $21.97 | 2022 | |
| Alk-Abello, INC | $19.91 | 2025 | Neffy |
| Pfizer INC. | $19.40 | 2024 | |
| Novartis Pharmaceuticals Corporation | $18.45 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $16.10 | 2021 | |
| Biomerieux INC | $16.00 | 2025 | Biofire Spotfire Control Station |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $15.90 | 2024 | Aptima |
| Cranial Technologies, INC | $14.85 | 2022 | |
| Sanofi Pasteur INC. | $13.96 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Saunders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.